Liarozole

DB13066InvestigationalSmall molecule

Liarozole has been used in trials studying the treatment of Ichthyosis, Lamellar.

Chemical structure of Liarozole
Formula / weight
C17H13ClN4 · 308.77 g/mol (avg)

Resolves to

Compound
UNIIK0Q29TGV9YCAS115575-11-6ChEMBLCHEMBL389433ChEBI135316PubChem60652
Structure
InChIKeyUGFHIPBXIWJXNA-UHFFFAOYSA-NSMILESClC1=CC=CC(=C1)C(N1C=CN=C1)C1=CC=C2N=CNC2=C1
Targets
P11511CYP19A1O43174CYP26A1

What you can answer from here — as of April 02, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Liarozole, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In